Cardlytics (NASDAQ: CDLX) runs a purchase intelligence platform that converts transaction data into targeted offers and rewards for consumer brands. These are delivered through banking and commerce platforms in the United States and the United Kingdom. With access to roughly 50% of card-based transactions in those markets, the company operates a leading card-linked offer network that supports performance-based advertising for brands while helping publishers deliver relevant offers to customers.
The core approach centers on an advertising and rewards network powered by verified purchase data. Advertisers pay based on measurable results, and banks integrate the offers into their apps and programs. I find the business interesting because it sits at the overlap of digital advertising, fintech, and spending data, especially given the recent revenue contraction tied to partnership shifts and efforts to expand into non-bank channels.
In the last 30 days, CDLX has declined approximately 35%, moving from a closing price near $2.13 to roughly $1.38. The move was not steady; shares briefly climbed back above $2.10 in early November before dropping sharply after the third-quarter earnings release.
The three-month view shows a steeper decline. Shares traded near $4.20 about three months ago, so the stock has lost roughly 65% over that period. This reflects an ongoing downtrend linked to lower billings and revenue, prior changes in bank partnerships, and increased attention on the balance sheet and return to growth.
The main driver was the third-quarter 2026 earnings report released in early November. Results missed the company's guidance, with revenue falling 30% year over year to $32.9 million and billings declining 32% to $57.2 million. Adjusted EBITDA narrowed to $0.4 million from $3.3 million a year earlier, and free cash flow stayed negative at $1.6 million.
Management pointed to a technical issue at a UK bank partner that blocked offers from reaching consumers for some time, plus tighter budgets from advertisers, especially in grocery where spending moved to other formats. These elements disrupted the sequential recovery path previously outlined, and the stock reacted accordingly. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Liquidity added pressure. The company finished the quarter with $29.9 million in cash and equivalents and roughly $10.4 million available on its credit facility, and it noted it is reviewing options to strengthen the balance sheet. Positive notes included new card-linked rewards partnerships with Yahoo, Vodafone Three, Rove, and Coupert, along with a Q4 outlook for sequential billings growth.
The quarterly drop fits into a longer story of contraction and transition. Cardlytics sold its Bridg platform earlier in 2026 to focus on its core business and continues to face tough year-over-year comparisons from the exit of a major U.S. financial-institution partner. Monthly qualified users fell to 187 million from 230 million a year earlier due to those relationship changes.
The company has worked to diversify supply by adding non-bank partners in telecom, online media, travel, and cashback areas. New-business billings grew 25% sequentially, and adjusted contribution margin rose to 59% of revenue. Even so, the revenue decline and balance-sheet questions have shaped investor views and kept the stock under pressure.
Attention will center on whether Cardlytics meets its Q4 guidance for billings between $63 million and $69 million and achieves sequential growth. Launches of the new partnerships and growth in advertiser cohorts will indicate if the top line can stabilize into 2027.
Other items to monitor include the UK billings recovery after the disruption, advertiser spending trends in grocery and discretionary categories, and progress on the balance sheet and cash flow. Macro conditions affecting consumer spending and ad budgets, plus any additional partner shifts, will also influence the stock.
When reviewing names like CDLX in volatile periods, I sometimes reference Tickeron’s AI Daily Buy/Sell Signals to get a sense of current momentum and compare it against historical patterns. It provides a quick, data-driven layer alongside the fundamentals and technicals.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
It is expected that a price bounce should occur soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +5.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where CDLX advanced for three days, in 203 of 257 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
CDLX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CDLX as a result. In 79 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
The Moving Average Convergence Divergence Histogram (MACD) for CDLX turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 41 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CDLX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for CDLX entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.718) is normal, around the industry mean (-1.802). P/E Ratio (-0.105) is within average values for comparable stocks, (21.593). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.501). Dividend Yield (0.000) settles around the average of (0.084) among similar stocks. P/S Ratio (0.114) is also within normal values, averaging (1.860).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 94 (best 1 - 100 worst), indicating slightly worse than average price growth. CDLX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CDLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of technology that enables online banking, mobile banking and card-linked marketing
Industry AdvertisingMarketingServices